Update on intrapartum fetal pulse oximetry

Christine E. East, Paul B. Colditz, Lisa M. Begg, Shaun P. Brennecke

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective To determine whether one should aim for glycaemia that is statistically 'normal' or for levels of glycaemia low enough to prevent macrosomia (if such a threshold exists) when glucose intolerance is detected during pregnancy Design An audit of pregnancy outcomes in women with impaired glucose tolerance in pregnancy as compared to a local age-matched reference group with normal glucose tolerance. Results Our study suggests that for most patients, more intensive therapy would not have been justified. Maternal smoking appeared to convey some 'advantages' in terms of neonatal outcomes, with reduction in large-for-gestational-age (LGA) infants and jaundice in babies of impaired glucose tolerance (IGT) mothers. Conclusions These observations demonstrate the importance of considering risk factors other than GTT results in analysing pregnancy outcomes, while emphasising that 'normalisation' of fetal size should not be our only therapeutic endpoint. Our detailed outcome review allows us to reassure patients with GDM that with current treatment protocols, they should have every expectation of a positive pregnancy outcome.

Original languageEnglish
Pages (from-to)23-28
Number of pages6
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume42
Issue number1
DOIs
Publication statusPublished - 1 Jan 2002
Externally publishedYes

Cite this